Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Larimar Therapeutics (LRMR) has a market cap of $0.12 billion USD. According to our data, Larimar Therapeutics is ranked No.7420 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $0.12 B |
-50.47%
|
| Dec 31, 2024 | $0.25 B |
-14.95%
|
| Dec 29, 2023 | $0.29 B |
10.17%
|
| Dec 30, 2022 | $0.26 B |
-61.72%
|
| Dec 31, 2021 | $0.69 B |
-49.60%
|
| Dec 31, 2020 | $1.37 B |
1,828.83%
|
| Dec 31, 2019 | $70.83 M |
-77.58%
|
| Dec 31, 2018 | $0.32 B |
7.14%
|
| Dec 29, 2017 | $0.29 B |
45.28%
|
| Dec 30, 2016 | $0.20 B |
-49.44%
|
| Dec 31, 2015 | $0.40 B |
-79.60%
|
| Dec 31, 2014 | $1.97 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
USA
|
 PTC Therapeutics
PTCT
|
$3.74 B |
-0.000 M
|
USA
|
 Amicus Therapeutics
FOLD
|
$2.10 B |
-0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
USA
|
 bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
USA
|
| Market Cap | = | LRMR Stock Price | * | LRMR Shares Outstanding |
| = | $1.91 | * | 64.03 M | |
| = | $0.12 B |